We keep the dates close to the Sermorelin claims
This guide is for anyone who has seen an old approval used to explain a new treatment. Maybe you’re looking up a children’s medicine. Maybe an adult prescription has raised questions. Either way, it helps to know which part of Sermorelin’s story you’re reading.

Our starting point
The year changes what a claim means
A study, an approval and a medicine leaving sale are different events. Put them into one sentence and it’s easy to lose track of what happened when. We keep the dates close so you don’t need to carry the whole history around in your head.
The children’s growth findings matter because they tell us something about children with a hormone shortage. The adult research asks different questions. We keep those groups separate, rather than letting a childhood result quietly become an assurance for adults.
Reading the studies
A smaller claim can be more useful
A blood hormone can rise without showing that someone sleeps better or feels younger. Our research page follows that difference. It also explains why a trial of thinking skills using tesamorelin, a related medicine, can’t be treated as a Sermorelin result.
Each research link sits beside the finding it helps explain. The sources page collects those links for anyone who wants to read further. We include the limits that change what a result means: who was studied, what was measured and how long the study ran. A few clear findings beat a pile of impressive-looking numbers.
The prescription service
A current option still needs current questions
Promise Peptides appears on our home page as a service offering prescription peptide therapy. A clinician reviews requests, and not everyone qualifies. The mention doesn’t tell a reader whether treatment suits them or predict that they’ll benefit.
The same questions remain useful in any adult prescription conversation. What is treatment meant to help, which evidence supports that aim, and what remains unknown? The access page explains the difference between an individual prescription and a product’s FDA status. Compounded Sermorelin is not FDA-approved.
What we hope you leave with
A clearer question is a worthwhile result. So is understanding why an old approval doesn’t settle a new claim. There’s no need to pretend the research is complete to make it easier to read.
This information guide gives no medical advice, diagnoses or personal treatment plans. The dose page describes what named studies used, with their participants and purposes attached. Questions about care belong with a clinician who can assess the person involved. These pages can help explain the history before that conversation begins.